Host-Pathogen Interaction in Invasive Salmonellosis

PLoS Pathogens

Volumn 8, Issue 10, 2012, Pages

  de Jong, Hanna K ^a   Parry, Chris M ^b,c   van der Poll, Tom ^a   Wiersinga, W Joost ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; POLYSACCHARIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; BACTERIAL GENOME; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; FIMBRIA; FLAGELLUM; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LIFE CYCLE; MACROPHAGE; MICROBIOME; NEUTROPHIL; NONHUMAN; PATHOGENICITY ISLAND; PLASMID; PROPHAGE; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; TYPE III SECRETION SYSTEM; TYPHOID FEVER;

ANIMALS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMASOMES; INTESTINES; MACROPHAGES; MICE; NEUTROPHILS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; TOLL-LIKE RECEPTORS; TYPHOID FEVER;

MURINAE; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM;

EID: 84868089559     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002933     Document Type: Article

References (100)

1. Crump JA, Mintz ED, (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50: 241-246.
2. Connor BA, Schwartz E, (2005) Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 5: 623-628.
3. Tsolis RM, Young GM, Solnick JV, Baumler AJ, (2008) From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol 6: 883-892.
4. Arjyal A, Basnyat B, Koirala S, Karkey A, Dongol S, et al. (2011) Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 11: 445-454.
5. Beeching NJ, Parry CM, (2011) Outpatient treatment of patients with enteric fever. Lancet Infect Dis 11: 419-421.
6. Monack DM, Mueller A, Falkow S, (2004) Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2: 747-765.
7. Monack DM, (2011) Salmonella persistence and transmission strategies. Curr Opin Microbiol 15: 100-107.
8. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ, (2002) Typhoid fever. N Engl J Med 347: 1770-1782.
9. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA, (2012) Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379: 2489-2499.
10. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, et al. (2010) The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50: 882-889.
11. Graham SM, (2010) Nontyphoidal salmonellosis in Africa. Curr Opin Infect Dis 23: 409-414.
12. Parry CM, Threlfall EJ, (2008) Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21: 531-538.
13. Baker S, (2011) Genomic medicine has failed the poor. Nature 478: 287.
14. Deng W, Liou SR, Plunkett G III, Mayhew GF, Rose DJ, et al. (2003) Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 185: 2330-2337.
15. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, et al. (2001) Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413: 848-852.
16. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, et al. (2001) Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413: 852-856.
17. Baker S, Dougan G, (2007) The genome of Salmonella enterica serovar Typhi. Clin Infect Dis 45 Suppl 1: S29-S33.
18. Achtman M, Wain J, Weill FX, Nair S, Zhou Z, et al. (2012) Multilocus sequence typing as a replacement for serotyping in salmonella enterica. PLoS Pathog 8: e1002776 doi:10.1371/journal.ppat.1002776.
19. Raffatellu M, Wilson RP, Winter SE, Baumler AJ, (2008) Clinical pathogenesis of typhoid fever. J Infect Dev Ctries 2: 260-266.
20. Sabbagh SC, Forest CG, Lepage C, Leclerc JM, Daigle F, (2010) So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. FEMS Microbiol Lett 305: 1-13.
21. Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, et al. (2009) Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19: 2279-2287.
22. Ehrbar K, Hardt WD, (2005) Bacteriophage-encoded type III effectors in Salmonella enterica subspecies 1 serovar Typhimurium. Infect Genet Evol 5: 1-9.
23. Lesnick ML, Reiner NE, Fierer J, Guiney DG, (2001) The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol Microbiol 39: 1464-1470.
24. Huang R, Wu S, Zhang X, Zhang Y, (2005) Molecular analysis and identification of virulence gene on pR(ST98) from multi-drug resistant Salmonella typhi. Cell Mol Immunol 2: 136-140.
25. Wu S, Li Y, Xu Y, Li Q, Chu Y, et al. (2010) A Salmonella enterica serovar Typhi plasmid induces rapid and massive apoptosis in infected macrophages. Cell Mol Immunol 7: 271-278.
26. Baker S, Hardy J, Sanderson KE, Quail M, Goodhead I, et al. (2007) A novel linear plasmid mediates flagellar variation in Salmonella Typhi. PLoS Pathog 3: e59 doi:10.1371/journal.ppat.0030059.
27. Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, et al. (2009) Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother 53: 716-727.
28. Phan MD, Wain J, (2008) IncHI plasmids, a dynamic link between resistance and pathogenicity. J Infect Dev Ctries 2: 272-278.
29. Holt KE, Phan MD, Baker S, Duy PT, Nga TV, et al. (2011) Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 5: e1245 doi:10.1371/journal.pntd.0001245.
30. Bhutta ZA, (1996) Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 75: 214-217.
31. Wain J, Diep TS, Ho VA, Walsh AM, Nguyen TT, et al. (1998) Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36: 1683-1687.
32. Thomson N, Baker S, Pickard D, Fookes M, Anjum M, et al. (2004) The role of prophage-like elements in the diversity of Salmonella enterica serovars. J Mol Biol 339: 279-300.
33. Terebiznik MR, Vieira OV, Marcus SL, Slade A, Yip CM, et al. (2002) Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol 4: 766-773.
34. Hernandez LD, Hueffer K, Wenk MR, Galan JE, (2004) Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304: 1805-1807.
35. Knodler LA, Finlay BB, Steele-Mortimer O, (2005) The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J Biol Chem 280: 9058-9064.
36. Ibarra JA, Steele-Mortimer O, (2009) Salmonella-the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol 11: 1579-1586.
37. Fang FC, DeGroote MA, Foster JW, Baumler AJ, Ochsner U, et al. (1999) Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc Natl Acad Sci U S A 96: 7502-7507.
38. Figueroa-Bossi N, Bossi L, (1999) Inducible prophages contribute to Salmonella virulence in mice. Mol Microbiol 33: 167-176.
39. Galan JE, (1999) Interaction of Salmonella with host cells through the centisome 63 type III secretion system. Curr Opin Microbiol 2: 46-50.
40. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. (1999) Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401: 804-808.
41. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2: 361-367.
42. Hensel M, Shea JE, Waterman SR, Mundy R, Nikolaus T, et al. (1998) Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 30: 163-174.
43. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, et al. (2000) Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287: 1655-1658.
44. Gallois A, Klein JR, Allen LA, Jones BD, Nauseef WM, (2001) Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol 166: 5741-5748.
45. Forest CG, Ferraro E, Sabbagh SC, Daigle F, (2010) Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology 156: 3689-3698.
46. Yoon H, Ansong C, Adkins JN, Heffron F, (2011) Discovery of Salmonella virulence factors translocated via outer membrane vesicles to murine macrophages. Infect Immun 79: 2182-2192.
47. Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, et al. (2003) Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115: 25-35.
48. Alaniz RC, Deatherage BL, Lara JC, Cookson BT, (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 179: 7692-7701.
49. Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, et al. (2003) Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171: 3668-3674.
50. Winter SE, Thiennimitr P, Nuccio SP, Haneda T, Winter MG, et al. (2009) Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection. Infect Immun 77: 1904-1916.
51. Lockman HA, Curtiss R 3rd, (1990) Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect Immun 58: 137-143.
52. Schmitt CK, Ikeda JS, Darnell SC, Watson PR, Bispham J, et al. (2001) Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect Immun 69: 5619-5625.
53. Wain J, House D, Zafar A, Baker S, Nair S, et al. (2005) Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan. J Clin Microbiol 43: 1158-1165.
54. Zhang XL, Jeza VT, Pan Q, (2008) Salmonella typhi: from a human pathogen to a vaccine vector. Cell Mol Immunol 5: 91-97.
55. Kolyva S, Waxin H, Popoff MY, (1992) The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus. J Gen Microbiol 138: 297-304.
56. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, et al. (2008) The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 10: 876-890.
57. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
58. Schroder K, Tschopp J, (2010) The inflammasomes. Cell 140: 821-832.
59. Butler T, Ho M, Acharya G, Tiwari M, Gallati H, (1993) Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 37: 2418-2421.
60. Butler T, Bell WR, Levin J, Linh NN, Arnold K, (2011) Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med 138: 407-410.
61. Keuter M, Dharmana E, Gasem MH, van dV, Djokomoeljanto R, et al. (1994) Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 169: 1306-1311.
62. Raffatellu M, Chessa D, Wilson RP, Tukel C, Akcelik M, et al. (2006) Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun 74: 19-27.
63. Thompson LJ, Dunstan SJ, Dolecek C, Perkins T, House D, et al. (2009) Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci U S A 106: 22433-22438.
64. Monack DM, Bouley DM, Falkow S, (2004) Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 199: 231-241.
65. Kupz A, Guarda G, Gebhardt T, Sander LE, Short KR, et al. (2012) NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8(+) T cells. Nat Immunol 13: 162-169.
66. Mastroeni P, Clare S, Khan S, Harrison JA, Hormaeche CE, et al. (1999) Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 67: 478-483.
67. de Jong HK, van der Poll T, Wiersinga WJ, (2010) The systemic pro-inflammatory response in sepsis. J Innate Immun 2: 422-430.
68. van der Poll T, Opal SM, (2008) Host-pathogen interactions in sepsis. Lancet Infect Dis 8: 32-43.
69. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, et al. (2010) The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 6: e1001097 doi:10.1371/journal.ppat.1001097.
70. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, et al. (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14: 421-428.
71. Gordon MA, Kankwatira AM, Mwafulirwa G, Walsh AL, Hopkins MJ, et al. (2010) Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis. Clin Infect Dis 50: 953-962.
72. O'Brien AD, Rosenstreich DL, Taylor BA, (1980) Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci. Nature 287: 440-442.
73. Weinstein DL, Lissner CR, Swanson RN, O'Brien AD, (1986) Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. Cell Immunol 102: 68-77.
74. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, et al. (2004) Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 172: 6202-6208.
75. Winter SE, Raffatellu M, Wilson RP, Russmann H, Baumler AJ, (2008) The Salmonella enterica serotype Typhi regulator TviA reduces interleukin-8 production in intestinal epithelial cells by repressing flagellin secretion. Cell Microbiol 10: 247-261.
76. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, et al. (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11: 1136-1142.
77. Raupach B, Peuschel SK, Monack DM, Zychlinsky A, (2006) Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect Immun 74: 4922-4926.
78. Lara-Tejero M, Sutterwala FS, Ogura Y, Grant EP, Bertin J, et al. (2006) Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med 203: 1407-1412.
79. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, et al. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7: 576-582.
80. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7: 569-575.
81. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, et al. (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A 107: 3076-3080.
82. Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, et al. (2010) Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 207: 1745-1755.
83. Broz P, Monack DM, (2011) Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 243: 174-190.
84. Fink SL, Cookson BT, (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73: 1907-1916.
85. Hueffer K, Galan JE, (2004) Salmonella-induced macrophage death: multiple mechanisms, different outcomes. Cell Microbiol 6: 1019-1025.
86. Hernandez LD, Pypaert M, Flavell RA, Galan JE, (2003) A Salmonella protein causes macrophage cell death by inducing autophagy. J Cell Biol 163: 1123-1131.
87. Brodsky IE, Monack D, (2009) NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol 21: 199-207.
88. Crawford RW, Rosales-Reyes R, Ramirez-Aguilar MdeL, Chapa-Azuela O, Alpuche-Aranda C, et al. (2010) Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci U S A 107: 4353-4358.
89. Everest P, Wain J, Roberts M, Rook G, Dougan G, (2001) The molecular mechanisms of severe typhoid fever. Trends Microbiol 9: 316-320.
90. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
91. Kaiser P, Diard M, Stecher B, Hardt WD, (2012) The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response. Immunol Rev 245: 56-83.
92. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH, (2009) Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 77: 2741-2753.
93. Gopinath S, Carden S, Monack D, (2012) Shedding light on Salmonella carriers. Trends Microbiol 20: 320-327.
94. Thiennimitr P, Winter SE, Baumler AJ, (2012) Salmonella, the host and its microbiota. Curr Opin Immunol 15: 108-114.
95. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, et al. (2010) Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426-429.
96. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, et al. (2001) Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 3: 1335-1344.
97. Dunstan SJ, Ho VA, Duc CM, Lanh MN, Phuong CX, et al. (2001) Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis 183: 1156-1160.
98. Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, et al. (2010) A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 8: 369-376.
99. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, et al. (2010) Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A 107: 15589-15594.
100. Hoffman SL, Punjabi NH, Kumala S, Moechtar MA, Pulungsih SP, et al. (1984) Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 310: 82-88.